AI News NQ Analysis

【ScinoPharm】Important Resolutions of the 115 Annual General Shareholders' Meeting

NQ Score 49/100
N1 Content Completeness 10

AI Summary (NQ-processed)

ScinoPharm held its Annual General Shareholders' Meeting on May 27, 115, approving a cash dividend of 0.29 TWD per share for the 114 fiscal year. The meeting also passed amendments to the Articles of Incorporation, asset disposal procedures, and the lifting of non-compete restrictions for directors.

AI Analysis

Frequently Asked Questions

Q: When will the dividends be paid?
A: The specific payment date will be announced separately by the company.
Q: What does lifting non-compete restrictions mean?
A: It allows directors to hold positions in other companies, facilitating broader industry collaboration.